Calendar

Events that a source expects, grouped by the month, quarter or half-year the source names, with who expected each and when they said so.

Upcoming as of , the date this release was built (the newest input commit date), not today's date. An expected date is a statement by the source, not a result, and it can move. Dated events are on the timeline.

8,817 of these dates come from registry records: the start, primary completion or completion that a registry expects of a trial. A program assembled them, and a registry often leaves a date unchanged after it has passed. The calendar file lists the dates of written pages only.

Add to your calendar (calendar.ics)

The calendar file has one all-day event for each upcoming item. Where a source gives only a month, a quarter, a half-year or a year, the event sits on the first day of that period and its title says "expected sometime in" the period.

Upcoming

January 2028 86

  1. Primary completion Recombinant Factor VIIa (rFVIIa) for Hemorrhagic Stroke Trial Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT03496883

  2. Study completion Drug-Coated Balloon in Anticoagulated and Bleeding Risk Patients Undergoing PCI Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT04814212

  3. Primary completion CRIC Combined With MFT for Cardiovascular Adverse Events in Patients With Incomplete Revascularization of CAD Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT06820970

  4. Study completion Perioperative Intensive Statin Therapy for Neuroprotection in TAVR(PISTNT) Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07087379

  5. Study completion Assessment of the Prevalence of Rheumatic Heart Disease in School Settings in Mayotte and the Acquisition of Ultrasound Sequences Guided by Artificial Intelligence Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07904975

  6. Primary completion Assessment of the Prevalence of Rheumatic Heart Disease in School Settings in Mayotte and the Acquisition of Ultrasound Sequences Guided by Artificial Intelligence Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07904975

  7. Study completion Randomized Trial of TAVI vs. SAVR in Patients With Severe Aortic Valve Stenosis at Low to Intermediate Risk of Mortality Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT03112980

  8. Primary completion Randomized Trial of TAVI vs. SAVR in Patients With Severe Aortic Valve Stenosis at Low to Intermediate Risk of Mortality Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT03112980

  9. Study completion Multicentre Study of MITRACLIP® Transcatheter Mitral Valve Repair in Patients With Severe Primary Mitral Regurgitation Eligible for High-risk Surgery Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT03271762

  10. Study completion Antibiotic Prophylaxis in High-Risk Arthroplasty Patients Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT04297592

  11. Primary completion Statins for Venous Event Reduction in Patients With Venous Thromboembolism Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT04319627

  12. Study completion Effect of PCSK9 Inhibitors on Calcific Aortic Valve Stenosis Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT04968509

  13. Study completion BOLT-DVT: Study of the Indigo® Aspiration System When Used in Patients With Deep Vein Thrombosis Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT05003843

  14. Primary completion POHCA Resuscitation: Evaluation of IM Epinephrine Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT05166343

  15. Primary completion DurAVR™ THV System: EMBARK Study Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT05182307

  16. Study completion A Clinical Investigation to Evaluate the Safety and Efficacy of IBS in Patients With Coronary Artery Disease Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT05206084

  17. Primary completion Pragmatic Amiodarone Trial to Reduce Postoperative Atrial Fibrillation in Patients Undergoing Cardiac Surgery Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT05543278

  18. Primary completion Diuretics Alone vs. Aortix Endovascular Device for Acute Heart Failure Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT05677100

  19. Primary completion Anti-inflammatory and Anti-thrombotic Therapy With colcHicine and Low Dose Rivaroxaban for Major Adverse Cardiovascular Events Reduction in Ischemic Stroke Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT06396858

  20. Primary completion Xeltis Hemodialysis Access Graft (aXess) US Study Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT06494631

  21. Study completion A Study of Mosliciguat in PH-ILD Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT06635850

  22. Study completion Repeat Ablation of Persistent Atrial Fibrillation, Including Mitral Isthmus Catheter Ablation, With the FARAPULSE Pulsed Field Ablation System Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT06735534

  23. Study completion The Fifth INTEnsive pReventing Secondary Injury in Acute Cerebral Haemorrhage Trial Within ACT-GLOBAL Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT06763055

  24. Primary completion The Fifth INTEnsive pReventing Secondary Injury in Acute Cerebral Haemorrhage Trial Within ACT-GLOBAL Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT06763055

  25. Study completion Finerenone Treatment for Diabetic Cardiovascular Autonomic Neuropathy: the FibroCAN Study Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT06906081

  26. Primary completion Finerenone Treatment for Diabetic Cardiovascular Autonomic Neuropathy: the FibroCAN Study Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT06906081

  27. Study completion NS-PFA Catheter Ablation of Paroxysmal Atrial Fibrillation With the Pulse Biosciences CellFX System Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07018596

  28. Primary completion Drug-Eluting Balloon Treatment vs. Guideline-Directed Medical Therapy for the Treatment of Lipid-Rich Plaques Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07107971

  29. Primary completion CaRi-Heart Assessment of Risk and Evaluation of Inflammation in Coronary CT Angiography (CARE-CCTA) Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07220304

  30. Primary completion Efficacy of Carbonlife Amniotic Tissue Product in the Treatment of Chronic Wounds Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07223892

  31. Primary completion A Study of Eloralintide (LY3841136) in Participants With Obesity or Overweight, and Type 2 Diabetes Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07282600

  32. Primary completion Elite AF IDE Trial (Elite AF) Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07287436

  33. Primary completion Conduction System Pacing and AV Junction Ablation in Heart Failure With Atrial Fibrillation (SYNC AF-HTx) Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07332871

  34. Primary completion Intravascular Ultrasound Imaging Guidance for Optimal Revascularization of Limb Arteries Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07353905

  35. Primary completion Efficacy and Safety of Compression Boots in Patients With Acute Decompensated Heart Failure. Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07377019

  36. Study completion A Study to Evaluate Efficacy and Safety of HM11260C in Patients With Type 2 Diabetes Mellitus Inadequately Controlled With Metformin and Dapagliflozin Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07379333

  37. Primary completion Apixaban VS Warfarin in AF Pts First Three Months After Repair or BIO AVR MVR Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07434661

  38. Study completion Huayu Jiedu Formula (FTFY-919) Granules Versus Traditional Decoction for Acute Hypertensive Intracerebral Hemorrhage Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07801599

  39. Primary completion A Study Comparing SHR-3167 With Insulin Degludec in Adults With Type 2 Diabetes Currently Treated With Basal Insulin Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07913061

  40. Primary completion MUTTON-HF Pilot Expansion Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07922863

  41. Study completion Evaluate the Efficacy of an Oral Health Behavioral Intervention in People With Diabetes Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07619729

  42. Primary completion Evaluate the Efficacy of an Oral Health Behavioral Intervention in People With Diabetes Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07619729

  43. Primary completion Pentoxifylline in Diabetic Kidney Disease Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT03625648

  44. Study completion Effects and Feasibility of Photobiomodulation at 830nm Nanometers in the Treatment of Diabetic Ulcers Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07043868

  45. Study completion Evaluation of Liver Stiffness Performance, by FibroScan®, to Detect Elevated Central Venous Pressure (CVP) Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07222813

  46. Primary completion Neuralert Stroke Monitor Trial Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07362303

  47. Primary completion Permanent Conduction System Pacing Versus Atrioventricular Management for Patients With Wide QRS and Patent AV Conduction Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07585799

  48. Primary completion Fuling Yunhua Granules and Dihuang Baoyuan Granules in Adults With Type 2 Diabetes and Poor Glycemic Control Despite Lifestyle Intervention Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07920640

  49. Primary completion Fuling Yunhua Granules and Dihuang Baoyuan Granules in Adults With Type 2 Diabetes and Inadequate Glycemic Control on Metformin Therapy Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07929350

  50. Primary completion Colchicine Versus Placebo in Acute Myocarditis Patients Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT05855746

  51. Study completion To Evaluate the Performance and Safety of RisoR Crest Everolimus Eluting Coronary Stent System Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07098195

  52. Primary completion A Study to Test Whether Survodutide Helps People With Type 2 Diabetes Control Their Blood Sugar Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07754461

  53. Primary completion Bacillus Subtilis and Enterococcus Faecium Probiotic Plus Lipid-Lowering Therapy for Hypertriglyceridemic Acute Pancreatitis: A Prospective RCT Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07720232

  54. Primary completion Single vs. Dual Antiplatelet Therapy in Elderly or HBR Patients Undergoing Percutaneous Intervention With DCB (PICCOLETO IV-EPIC 38) Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT06535568

  55. Study completion Efficacy of Early Intravenous High-dose Vitamin C in Post-cardiac Arrest Shock. Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT05817851

  56. Study completion A Study of Zigakibart in Adults With IgA Nephropathy Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT05852938

  57. Primary completion Impact of Beta Blockers on TAVI (BETA-TAVI) Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT05721170

  58. Study completion Adjuvant Cerebroprotection Using Normobaric Hyperoxia in Pre-hospital Patients with Suspected Stroke Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT06801457

  59. Primary completion Adjuvant Cerebroprotection Using Normobaric Hyperoxia in Pre-hospital Patients with Suspected Stroke Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT06801457

  60. Primary completion Efficacy of Remote Ischemic Conditioning for Hypertension in High-Altitude Immigrant Populations Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07562477

  61. Study completion IV-X Medical Peripheral Intravascular Lithotripsy Study for PAD Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07746362

  62. Primary completion DEFIANCE: RCT of ClotTriever System Versus Anticoagulation In Deep Vein Thrombosis Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT05701917

  63. Study completion Impact of Beta Blockers on TAVI (BETA-TAVI) Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT05721170

  64. Study completion CPAP Effect on Lipid Profile and Hyperuricemia in Patients With Dyslipidemia and Moderate-severe Obstructive Sleep Apnea Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT06463561

  65. Study completion Early Amiodarone in Shockable Cardiac Arrest Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT06680869

  66. Study completion Robotic Rehabilitation of the Upper Limb in Subacute Stroke Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT06839482

  67. Primary completion Use of PRP in Open Surgery for Type A Aortic Dissection Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07005661

  68. Study completion Efficacy of Semaglutide in Improving Neurological Outcomes After Endovascular Thrombectomy for Acute Ischemic Stroke: A Randomized Double-Blind Controlled Trial Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07030621

  69. Study completion A Study to Evaluate the Safety, Efficacy of SYH2053 as Monotherapy in Chinese Participants With Non-familial Hypercholesterolemia or Mixed Hyperlipidemia Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07421297

  70. Study completion Safety and Efficacy of Baricitinib After Endovascular Treatment in Acute Anterior Circulation Large Vessel Occlusion: A Multicenter, Randomized Controlled Clinical Trial Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07449910

  71. Primary completion POcus INTERvention for Tailoring Diuretic Strategy in Acute Decompensated Heart Failure Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07469722

  72. Primary completion Ciprofol vs Propofol for Hemodynamic Stability in Patients Having General Anesthesia for Endovascular Thrombectomy After Ischemic Stroke Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07696208

  73. Study completion AI-Assisted Lifestyle Intervention Versus Tirzepatide for Obesity and Newly Diagnosed Type 2 Diabetes Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07697391

  74. Primary completion Motor Cortex Stimulation for Post-Stroke Thalamic Pain Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07758829

  75. Primary completion Prophylactic IABP in Delayed-Presentation Anterior STEMI Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07761455

  76. Study completion Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of PAL-119 in Healthy Volunteers and Adult Participants With Type 1 or Type 2 Diabetes Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07901595

  77. Study completion Swiss Pilot Screening Study for Unruptured Intracranial Aneurysms to Prevent Subarachnoid Hemorrhage in Smokers Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07938775

  78. Study completion Sotagliflozin Versus Empagliflozin Added to Metformin for Glycemic Control in Type 2 Diabetes Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07939750

February 2028 67

  1. Primary completion Temsirolimus Adventitial Delivery to Improve ANGioplasty and/or Atherectomy Revascularization Outcomes Below the Knee Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT04433572

  2. Study completion Maturation of Arteriovenous Fistula With Automated Sonography Assessments Trial Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT06190717

  3. Primary completion Maturation of Arteriovenous Fistula With Automated Sonography Assessments Trial Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT06190717

  4. Primary completion Physiology of Unloading VA ECMO Trial Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT06336655

  5. Study completion DCB vs. DES in Bifurcation Coronary Lesions Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT06551662

  6. Study completion CGUARDIANS III IDE Pivotal Trial Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07277296

  7. Study completion Safety and Efficacy of CAG and PCI Via Distal Transradial Access in Patients With Small Vessels Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07410364

  8. Primary completion Safety and Efficacy of CAG and PCI Via Distal Transradial Access in Patients With Small Vessels Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07410364

  9. Study completion Modulation of Cerebral Ischemia by Albumin Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07415655

  10. Study completion Remote ECG Monitoring Post TAVI Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07521800

  11. Study completion Cyclosporine In Takotsubo Syndrome Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT05946772

  12. Primary completion Prehospital Resuscitation Intranasal Cooling Effectiveness Survival Study 2 Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT06025123

  13. Study completion Liquid Biopsy System Intracoronary Blood Sampling and Analysis to Characterise Disease Biomarkers in Patients With Coronary Disease Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT06259019

  14. Study completion Structured Testing and Treatment for Obstructive Sleep Apnea in Patients With Atrial Fibrillation Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT06263608

  15. Primary completion Structured Testing and Treatment for Obstructive Sleep Apnea in Patients With Atrial Fibrillation Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT06263608

Overdue

The expected date has passed and no published record says the event happened. This does not mean it failed or was delayed: the atlas may not have checked the source since. Oldest first.

  1. Study completion Rivaroxaban or Aspirin for Biological Aortic Prosthesis Registry record

    Expected 2022-11; that period ended on 2022-11-30.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT02974920

  2. Primary completion Intracavitary Injection of hUMSCs in Acute Basal Ganglia Hematoma After Stereotactic Aspiration Registry record

    Expected 2022-11; that period ended on 2022-11-30.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT04074408

  3. Study completion New Designed ePTFE Valved Conduits for Surgical Reconstruction of Right-ventricular Outflow Tract Registry record

    Expected 2022-11-30; that period ended on 2022-11-30.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT04152967

  4. Primary completion The Effect of Sacubitril/Valsartan on Cardiovascular Events in Dialysis Patients and Efficacy Prediction of Baseline LVEF Value Registry record

    Expected 2022-11; that period ended on 2022-11-30.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT04572724

  5. Primary completion BUN/Cr-based Hydration Therapy to Improve Outcome of Patients With Acute Ischemic Stroke Registry record

    Expected 2022-11-30; that period ended on 2022-11-30.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT05121389

  6. Primary completion The Use of a Monitoring Device by General Practitioners During Out-of-hours Care Registry record

    Expected 2022-11; that period ended on 2022-11-30.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT05222711

  7. Study start The Effect of Vitamin C and E Therapy on Restless Leg Syndrome in Patients With End Stage Renal Disease on Haemodialysis Registry record

    Expected 2022-11; that period ended on 2022-11-30.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT05350124

  8. Primary completion Drug Eluting Balloon Angioplasty Versus Everolimus Platinum Chrome Stent Registry record

    Expected 2022-11; that period ended on 2022-11-30.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT05516446

  9. Study start Clinical Study of Focal Implant Used for Lower Extremity Post-angioplasty Dissection Registry record

    Expected 2022-11; that period ended on 2022-11-30.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT05562076

  10. Study completion MOdularity for SEnsory Motor Control Registry record

    Expected 2022-12-01; that period ended on 2022-12-01.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT03530358

  11. Primary completion Mobile Health to Enhance Exercise in Type 2 Diabetes Registry record

    Expected 2022-12-01; that period ended on 2022-12-01.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT04653532

  12. Primary completion Edaravone Dexborneol for Treatment of Acute Ischemic Stroke With Endovascular Therapy in Extended Time Windows Registry record

    Expected 2022-12-01; that period ended on 2022-12-01.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT04817527

  13. Study completion Efficacy of Different Doses of Influenza Vaccine in Chronic Hemodialysis Patients Registry record

    Expected 2022-12-01; that period ended on 2022-12-01.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT05070494

  14. Study completion Clinical Of Chocolate Balloon Dilatation Versus Plain Balloon Dilatation to Treat Arteriosclerosis Occlusive Disease of Lower Extremity Registry record

    Expected 2022-12-01; that period ended on 2022-12-01.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT05158283

  15. Study start Clinical Efficacy of Extracorporeal Cardiac Shock Wave Therapy in Patients With Ischemia-reperfusion Injury Registry record

    Expected 2022-12-01; that period ended on 2022-12-01.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT05624203

  16. Study start Clinical Study of Endovascular Interventional Surgical Instrument Control System and Related Consumables in Lower Extremity Arteriosclerosis Occlusive Lumen Registry record

    Expected 2022-12-01; that period ended on 2022-12-01.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT05625711

  17. Study start Colchicine Use for Primary Prevention of Coronary Artery Disease Registry record

    Expected 2022-12-06; that period ended on 2022-12-06.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT05175274

  18. Study completion Postpartum NSAIDS and Maternal Hypertension Registry record

    Expected 2022-12-11; that period ended on 2022-12-11.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT03824119

  19. Primary completion Postpartum NSAIDS and Maternal Hypertension Registry record

    Expected 2022-12-11; that period ended on 2022-12-11.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT03824119

  20. Study completion S-Metoprolol XR 25-50 mg Tablets vs Metoprolol Zok 50-100 mg Tablets in Hypertension Patients. Registry record

    Expected 2022-12-15; that period ended on 2022-12-15.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT04457323

  21. Study start EMPAGUM: Effects of Empagliflozin on Gut Microbiota in Heart Failure With a Preserved Ejection Fraction Registry record

    Expected 2022-12-15; that period ended on 2022-12-15.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT05584319

  22. Study completion Systematic Investigation of Blacks With Stroke - GENOMICS Registry record

    Expected 2022-12-15; that period ended on 2022-12-15.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT05619406

  23. Primary completion Coronary Rotational Atherectomy Elective vs. Bailout in Severely Calcified Lesions and Chronic Renal Failure Registry record

    Expected 2022-12-27; that period ended on 2022-12-27.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT05353946

  24. Study completion Tryton Post Approval Study (PAS) for the Tryton Side Branch Stent Registry record

    Expected 2022-12-30; that period ended on 2022-12-30.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT03318796

  25. Study completion Early Intracoronary Administration of Fasudil in the Primary PCI of ST-segment-Elevation Myocardial Infarction Registry record

    Expected 2022-12-30; that period ended on 2022-12-30.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT03753269

  26. Study completion Prevention of Post-STEMI Left Ventricular Thrombus With Optimized Anticoagulant (EARLYmyo-LVT Ⅱ) Registry record

    Expected 2022-12-30; that period ended on 2022-12-30.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT03786757

  27. Primary completion Efficacy and Safety of Angong Niuhuang Wan for Stroke Registry record

    Expected 2022-12-30; that period ended on 2022-12-30.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT04236427

  28. Study completion A Study to Evaluate the Efficacy and Safety of Dual add-on Therapy With Gemigliptin 50 mg and Dapagliflozin 10 mg Added to Metformin Who Have Inadequate Glycemic Control on Metformin Alone Registry record

    Expected 2022-12-30; that period ended on 2022-12-30.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT04255238

  29. Study completion The Effect of Sitagliptin Treatment in COVID-19 Positive Diabetic Patients Registry record

    Expected 2022-12-30; that period ended on 2022-12-30.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT04365517

  30. Study completion WJMSCs Anti-inflammatory Therapy in Coronary Artery Disease Registry record

    Expected 2022-12-30; that period ended on 2022-12-30.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT04551456

  31. Study completion The Effectiveness and Safety of Levosimendan in Patients With Severe Aortic Stenosis and Heart Failure Undergoing Transcatheter Aortic Valve Replacement Registry record

    Expected 2022-12-30; that period ended on 2022-12-30.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT04573049

  32. Study completion Study on the Clinical and Mechanism of Wenyang Huoxue Decoction in Treating Heart Failure After Myocardial Infarction Registry record

    Expected 2022-12-30; that period ended on 2022-12-30.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT04695990

  33. Study start A Clinical Trial of the Transcatheter Aortic Valve Implantation System With a Prospective, Multi-Center, One-Arm Approach to Evaluate the Efficacy and Safety in the Treatment of Patients With Severe Aortic Stenosis Registry record

    Expected 2022-12-30; that period ended on 2022-12-30.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT05673525

  34. Study completion The Statins on Glucose Homeostasis in Subjects With Impaired Fasting Glucose Registry record

    Expected 2022-12; that period ended on 2022-12-31.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT01816997

  35. Study completion Impact of Intracoronary Injection of Autologous BMMC for LV Contractility and Remodeling in Patients With STEMI Registry record

    Expected 2022-12; that period ended on 2022-12-31.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT02323620

  36. Study completion European Sleep Apnea and Sudden CArdiac Death ProjEct Registry record

    Expected 2022-12; that period ended on 2022-12-31.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT02506166

  37. Primary completion Inpatient Blood Glucose Control in Taichung Veterans General Hospital Registry record

    Expected 2022-12; that period ended on 2022-12-31.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT02885909

  38. Study completion Pupillometry in Horner's Syndrome Registry record

    Expected 2022-12-31; that period ended on 2022-12-31.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT02978079

  39. Primary completion Remote Ischemic Conditioning Paired With Endovascular Treatment for Acute Ischemic Stroke Registry record

    Expected 2022-12-31; that period ended on 2022-12-31.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT03045055

  40. Study completion Platelet Inhibition to Target Reperfusion Injury Registry record

    Expected 2022-12; that period ended on 2022-12-31.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT03102723

  41. Primary completion Platelet Inhibition to Target Reperfusion Injury Registry record

    Expected 2022-12; that period ended on 2022-12-31.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT03102723

  42. Study completion Tenecteplase in Wake-up Ischaemic Stroke Trial Registry record

    Expected 2022-12-31; that period ended on 2022-12-31.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT03181360

  43. Study completion Effect of RAS Blockers on CKD Progression in Elderly Patients With Non Proteinuric Nephropathies (PROERCAN01) Registry record

    Expected 2022-12; that period ended on 2022-12-31.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT03195023

  44. Study completion Multifactorial Intervention on Diabetes (MIDiab Study) Registry record

    Expected 2022-12-31; that period ended on 2022-12-31.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT03430284

  45. Study completion Efficacy, Safety and Response Predictors of Adjuvant Astragalus Therapy for Diabetic Kidney Disease Registry record

    Expected 2022-12-31; that period ended on 2022-12-31.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT03535935

  46. Primary completion Preoperative Intravenous Ferric Carboxymaltose and Placebo in the Treatment of Patients Undergoing Cardiac Surgery Registry record

    Expected 2022-12; that period ended on 2022-12-31.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT03574311

  47. Primary completion A Non-Traumatic Binder for Temporary Abdominal Wall Closure Registry record

    Expected 2022-12-31; that period ended on 2022-12-31.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT03815370

  48. Study completion Carnosine for Peripheral Vascular Disease Registry record

    Expected 2022-12-31; that period ended on 2022-12-31.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT03844113

  49. Primary completion Carnosine for Peripheral Vascular Disease Registry record

    Expected 2022-12-31; that period ended on 2022-12-31.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT03844113

  50. Primary completion Study to Evaluate Effects of INL1 in Patients With Heart Failure and Reduced Ejection Fraction Registry record

    Expected 2022-12; that period ended on 2022-12-31.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT03875183

  51. Study completion Efficacy and Safety of Sotalol in Children With Arrhythmia Registry record

    Expected 2022-12; that period ended on 2022-12-31.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT03895411

  52. Study completion Discontinuation of Postmenopausal Hormone Therapy: Impact on the Cardiovascular System and Quality of Life Registry record

    Expected 2022-12; that period ended on 2022-12-31.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT04050592

  53. Primary completion Discontinuation of Postmenopausal Hormone Therapy: Impact on the Cardiovascular System and Quality of Life Registry record

    Expected 2022-12; that period ended on 2022-12-31.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT04050592

  54. Study completion Intervention of Air Pollution and Acute Coronary Syndrome Registry record

    Expected 2022-12-31; that period ended on 2022-12-31.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT04126434

  55. Primary completion Intervention of Air Pollution and Acute Coronary Syndrome Registry record

    Expected 2022-12-31; that period ended on 2022-12-31.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT04126434

  56. Primary completion Intraosseous Versus Intravenous Vascular Access During Resuscitation Following Out-of-Hospital Cardiac Arrest Registry record

    Expected 2022-12; that period ended on 2022-12-31.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT04130984

  57. Primary completion The Dose-Effect Relationship of Wenxin Granules in the Treatment of Atrial Premature Beats Registry record

    Expected 2022-12-31; that period ended on 2022-12-31.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT04163835

  58. Study completion NBP in Patients With Moyamoya Disease of High Risk for Ischemic Cerebrovascular Events Registry record

    Expected 2022-12-31; that period ended on 2022-12-31.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT04205578

  59. Primary completion NBP in Patients With Moyamoya Disease of High Risk for Ischemic Cerebrovascular Events Registry record

    Expected 2022-12-31; that period ended on 2022-12-31.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT04205578

  60. Study completion Excimer Laser Combined With DCB Compared With Angioplasty Alone in the Treatment of Infrapopliteal Lesions. Registry record

    Expected 2022-12-31; that period ended on 2022-12-31.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT04365075

  61. Primary completion Excimer Laser Combined With DCB Compared With Angioplasty Alone in the Treatment of Infrapopliteal Lesions. Registry record

    Expected 2022-12-31; that period ended on 2022-12-31.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT04365075

  62. Study completion BuqitongluO Granule for Qi Deficiency and Blood Stasis Syndrome Registry record

    Expected 2022-12; that period ended on 2022-12-31.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT04408261

  63. Primary completion BuqitongluO Granule for Qi Deficiency and Blood Stasis Syndrome Registry record

    Expected 2022-12; that period ended on 2022-12-31.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT04408261

  64. Primary completion Tirofiban for the Prevention of Neurological Deterioration in Acute Ischemic Stroke Registry record

    Expected 2022-12-31; that period ended on 2022-12-31.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT04491695

  65. Primary completion Efficacy of Different Anti-Thrombotic Strategies on Device-Related Thrombosis Prevention After Percutaneous Left Atrial Appendage Occlusion Registry record

    Expected 2022-12-31; that period ended on 2022-12-31.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT04502017

  66. Study completion Impact of Vitamin C on Biomarkers of Neurologic Injury in Survivors of Cardiac Arrest Registry record

    Expected 2022-12-31; that period ended on 2022-12-31.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT04563000

  67. Study start Magnesium Treating Subarachnoid Hemorrhage Vasospasm Registry record

    Expected 2022-12; that period ended on 2022-12-31.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT04613960

  68. Primary completion Remote Ischemic Conditioning for the Treatment of Intracerebral Hemorrhage Registry record

    Expected 2022-12-31; that period ended on 2022-12-31.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT04657133

  69. Study completion Comparison of Safety and Efficacy of Needle-Free Injector and Insulin Pen in Patients With T2DM Registry record

    Expected 2022-12-31; that period ended on 2022-12-31.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT04682795

  70. Primary completion Comparison of Safety and Efficacy of Needle-Free Injector and Insulin Pen in Patients With T2DM Registry record

    Expected 2022-12-31; that period ended on 2022-12-31.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT04682795

  71. Primary completion Dual Therapy With Dabigatran/Ticagrelor Versus Dual Therapy With Dabigatran/Clopidogrel in ACS Patients With Indication for NOAC Undergoing PCI Registry record

    Expected 2022-12-31; that period ended on 2022-12-31.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT04688723

  72. Primary completion Safety and Efficacy of Drug-Coated Balloon Angioplasty for the Treatment of Chronic Total Occlusions Registry record

    Expected 2022-12; that period ended on 2022-12-31.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT04744571

  73. Study completion Evaluate the Efficacy and Safety of DWJ1506 and DWJ1507 Registry record

    Expected 2022-12; that period ended on 2022-12-31.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT04772443

  74. Primary completion Evaluate the Efficacy and Safety of DWJ1506 and DWJ1507 Registry record

    Expected 2022-12; that period ended on 2022-12-31.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT04772443

  75. Study completion Edaravone Dexborneol for Treatment of Acute Ischemic Stroke With Endovascular Therapy in Extended Time Windows Registry record

    Expected 2022-12-31; that period ended on 2022-12-31.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT04817527

  76. Primary completion To Evaluate Safety and Effectiveness of Transcatheter Aortic Valve System in Patients With Severe Aortic Stenosis Registry record

    Expected 2022-12-31; that period ended on 2022-12-31.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT04893603

  77. Study completion Effect of Intravenous Ferric Carboxymaltose on Hemoglobin Response and Transfusion in Patients With Iron Deficiency Anemia After Off-Pump Coronary Artery Bypass Grafting Registry record

    Expected 2022-12-31; that period ended on 2022-12-31.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT04898569

  78. Study completion LLTS to Treat Premature Ventricular Contractions Registry record

    Expected 2022-12-31; that period ended on 2022-12-31.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT04909528

  79. Primary completion LLTS to Treat Premature Ventricular Contractions Registry record

    Expected 2022-12-31; that period ended on 2022-12-31.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT04909528

  80. Primary completion Effect of Acetazolamide on Right Heart Function at Rest in Lowlanders With COPD Traveling to High Altitude Registry record

    Expected 2022-12-31; that period ended on 2022-12-31.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT04915365

  81. Primary completion Tangningtongluo Tablet for People With Prediabetes Registry record

    Expected 2022-12-31; that period ended on 2022-12-31.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT05126251

  82. Study completion The Use of a Monitoring Device by General Practitioners During Out-of-hours Care Registry record

    Expected 2022-12; that period ended on 2022-12-31.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT05222711

  83. Primary completion Short-term Use of Dapagliflozin to Protect Kidney Function in CKD Patients Registry record

    Expected 2022-12-31; that period ended on 2022-12-31.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT05225077

  84. Primary completion Influenza Vaccination During Coronavirus Disease 2019 Outbreak After Acute Coronary Syndrome and Chronic Heart Failure Registry record

    Expected 2022-12-31; that period ended on 2022-12-31.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT05232292

  85. Primary completion NoYA RAISE Trial II (Radiofrequency Ablation-Based Interatrial Shunt for Heart Failure) Registry record

    Expected 2022-12-31; that period ended on 2022-12-31.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT05375110

  86. Primary completion The Effect and Safety of Pulsed Field Ablation (PFA) in Patients With Paroxysmal Atrial Fibrillation (PAF) Registry record

    Expected 2022-12-31; that period ended on 2022-12-31.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT05400928

  87. Primary completion Post-marketing Study in Femoral Popliteal Artery of Drug Coated Balloon Used for Treatment of Lower Limb Ischemia Registry record

    Expected 2022-12; that period ended on 2022-12-31.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT05498740

  88. Study completion Drug Eluting Balloon Angioplasty Versus Everolimus Platinum Chrome Stent Registry record

    Expected 2022-12; that period ended on 2022-12-31.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT05516446

  89. Study start Ad5FGF-4 In Patients With Refractory Angina Due to Myocardial Ischemia Registry record

    Expected 2023-01-01; that period ended on 2023-01-01.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT02928094

  90. Study start TROPHY PAH Pivotal Study - TReatment of Pulmonary HYpertension for PAH Pivotal Study Registry record

    Expected 2023-01-01; that period ended on 2023-01-01.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT04570228

  91. Primary completion Efficiency of an mHealth Intervention on the Health Literacy Improvement and Self-management. Registry record

    Expected 2023-01-01; that period ended on 2023-01-01.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT04725526

  92. Study completion Ivabradine Effects in Cardiogenic Shock Requiring Inotropic Support Registry record

    Expected 2023-01-01; that period ended on 2023-01-01.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT05594342

  93. Primary completion Ivabradine Effects in Cardiogenic Shock Requiring Inotropic Support Registry record

    Expected 2023-01-01; that period ended on 2023-01-01.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT05594342

  94. Study start DEX vs SEVO in Congenital Heart Surgery Registry record

    Expected 2023-01-05; that period ended on 2023-01-05.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT05369949

  95. Primary completion Effects of Respiratory Muscle Training in Patients With Acute Ischemic Stroke Registry record

    Expected 2023-01-15; that period ended on 2023-01-15.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT04949334

  96. Study start Pre-diltiazem, Calcium Versus Placebo for Atrial Fibrillation With Rapid Ventricular Response Registry record

    Expected 2023-01-26; that period ended on 2023-01-26.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT05691959

  97. Study completion Study to Evaluate Effects of INL1 in Patients With Heart Failure and Reduced Ejection Fraction Registry record

    Expected 2023-01; that period ended on 2023-01-31.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT03875183

  98. Study start Prevention of Post-Operative Cardiac Arrhythmias Registry record

    Expected 2023-01; that period ended on 2023-01-31.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT04234906

  99. Primary completion Intravascular Ultrasound Versus Angiography Guided Drug-coated Balloon Treatment for STEMI Patients:a Prospective, Multicenter, Randomized Controlled Trial Registry record

    Expected 2023-01-31; that period ended on 2023-01-31.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT04475978

  100. Study completion A Clinical Trial to Evaluate the Bone Metabolism and the Blood Sugar of Evogliptin and Dapagliflozin Registry record

    Expected 2023-01-31; that period ended on 2023-01-31.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT04706637